Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 11503801Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2024
Linked Award Amount
$1.6M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#7,507
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Daniel Bachovchin as a PI. Multi-PI records show the full award amount for context.
- 5R01CA266478-03R01Prolidase Inhibitors as Therapeutic Agents for Acute Myeloid Leukemia$609.1Kaward amount
- 5R01AI137168-07R01Characterizing the Mechanism of DPP8/9 Inhibitor-Induced Pyroptosis$523.8Kaward amount
- $512.3Kaward amount
Award organization
Organizations that administered FY2024 awards listing Daniel Bachovchin as a PI.
FY2024 award administered by Memorial Sloan Kettering Cancer Center (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMemorial Sloan Kettering Cancer Center
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #7507
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder